• 54,773+ CME Conference Registrations Sold
  • 164,320+ Medical Conferences
  • 297 Specialties
  • 11,712 Organizers
  • 159,479 Speakers
  • 159 Countries
  • 4,843 Cities
Duration: CME/CE Points: Author(s):
CE : 1

Quality Resource Guide: HPV and Oral Cancer is organized by MetLife. 

Originally published: May 2016
Expiration date: December 2019

MetLife designates this activity for 1.0 continuing education credit for the review of this Quality Resource Guide and successful completion of the post test.

Course Description:
Human Papilloma Virus (HPV) has emerged as a significant risk factor and is changing the epidemiology of oral cancer that occurs in the oropharynx. Since 1988, the prevalence of oral cancers associated with the traditional risk factors of smoking and drinking alcohol has decreased by 50% whereas the prevalence of those in the oropharynx associated with HPV infection has increased by 225%. It is estimated that over 50% of all oral cancers will be HPV-related by 2030. This Quality Resource Guide (QRG) discusses the epidemiology, prevention and dental considerations for HPV-associated oral cancer. It describes the principles of a thorough exam necessary to discover HIV-associated pharyngeal cancer, and appropriate referral if warranted. The dental team’s role in education of young men and women, and their parents, about HPV infection and preventive vaccines is also covered. Detailed tables will serve as a quick reference for the dentist when evaluating suspicious symptoms occurring in the oropharynx and for the dental team when discussing HPV vaccination with patients and parents. This QRG will serve as an important resource for the dentist, and members of the office staff, as they assist with management of this rapidly increasing oral health dilemma.

Educational Objectives:
• Understand the changing epidemiology of oral cancer and the emergence of HPV as a risk factor.
• Discuss the signs, symptoms and location of HPV-associated oral cancer.
• Understand the prognosis for HPV-associated oral cancer.
• Understand the relationship between specific sexual practices and increased risk for HPVassociated oral cancer.
• Recognize the critical points of an oral screening for HPV-associated oral cancer.
• Respond to patient questions about HPV infection and oral cancer and HPV vaccination.

Additional details will be posted as soon as they are available.

Target Audience

Oncology, Oral and Maxillofacial Surgery, Otorhinolaryngology, Infectious Disease, Obstetrics and Gynecology


Activity Fee : USD $12.00


Oncology, Oral and Maxillofacial Surgery, Otorhinolaryngology, Infectious Disease, Obstetrics and Gynecology

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.